who is selling?, page-17

'However, the stock has been substantially derisked'

Isnt the reality of time decay going to increase the risk of dilution somewhat?

Timelines have changed considerably. How wrong is the following scenario?

Q1 2013: Small CR of 10m for first US trial
Dec 2013: CEO Mark approved
Q1 2014: Medium CR of 14m for second trial, working capital (+stock), etc
Q4 2015: VitroGro profitable.

If the don't raise capital in 2013 they can't start either of the US trials. So they will need to do this I assume. I also suspect they won't want to raise 20m+ at such a low MC so they will need to do two CR's hoping the share price will be higher for the second which will reduce dilution. (But i see some here are expecting a large cr soon to pay for both trials)

I have had to sell my holding this year and encourage friends to do the some (some at a loss) unfortunately and all because I just can't see any good news in the near term.